Publications

Pagliaccetti, N.E., R. Eduardo, S.H. Kleinstein, X.J. Mu, P. Bandi, and M.D. Robek. 2008. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit HCV replication. J Biol Chem, 283:30079-30089.

Garcia, M.L., R. Byfield, and M.D. Robek. 2009. Hepatitis B virus replication and release are independent of core lysine ubiquitination. J Virol, 83:4923-4933.

Bandi, P., M.L. Garcia, C.J. Booth, F.V. Chisari, and M.D. Robek. 2010. Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob Agents and Chemother, 54:749-756.

Zhang Y, J.Q. Lian, C.X. Huang, J.P. Wang, X. Wei, X.P. Nan, H.T. Yu, L.L. Jiang, X.Q. Wang, Y. Zhuang, X.H. Li, Y. Li, P.Z. Wang, M.D. Robek, X.F. Bai. 2010. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology, 397:34-42.

Bandi, P., N.E. Pagliaccetti, and M.D. Robek. 2010. Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. J Interferon Cytokine Res, 30:123-134.

Pagliaccetti, N.E., E.N. Chu, C.R. Bolen, S.H. Kleinstein, and M.D. Robek. 2010. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology, 401: 197-206.

Cobleigh, M., L. Buonocore, S.L. Uprichard, J.K. Rose, and M.D. Robek. 2010.  A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge after a single dose. Journal of Virology, 84:7513-7522.